MedPath

Pemetrexed

These highlights do not include all the information needed to use PEMETREXED FOR INJECTION safely and effectively. See full prescribing information for PEMETREXED FOR INJECTION.PEMETREXED for injection, for intravenous useInitial U.S. Approval: 2004

Approved
Approval ID

a805883c-70cf-4bba-93d1-d60421e97eba

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 17, 2023

Manufacturers
FDA

Athenex Pharmaceutical Division, LLC.

DUNS: 080318964

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

pemetrexed disodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70860-203
Application NumberANDA207352
Product Classification
M
Marketing Category
C73584
G
Generic Name
pemetrexed disodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 17, 2023
FDA Product Classification

INGREDIENTS (4)

MannitolInactive
Code: 3OWL53L36A
Classification: IACT
Sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
Hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
PEMETREXED DISODIUM HEMIPENTAHYDRATEActive
Quantity: 500 mg in 20 mL
Code: F4GSH45R4C
Classification: ACTIM

pemetrexed disodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70860-202
Application NumberANDA207352
Product Classification
M
Marketing Category
C73584
G
Generic Name
pemetrexed disodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 17, 2023
FDA Product Classification

INGREDIENTS (4)

MannitolInactive
Code: 3OWL53L36A
Classification: IACT
Hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
Sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
PEMETREXED DISODIUM HEMIPENTAHYDRATEActive
Quantity: 100 mg in 4.2 mL
Code: F4GSH45R4C
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.